D
Lantern Pharma Inc. LTRN
$4.44 -$0.13-2.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 4.20% 1.95% 24.75% 11.36% -6.89%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -13.99% -16.71% 20.89% 47.00% 4.20%
Operating Income 13.99% 16.71% -20.89% -47.00% -4.20%
Income Before Tax 12.67% 16.62% -40.36% -42.52% -4.49%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 12.67% 16.62% -40.36% -42.52% -4.49%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 12.67% 16.62% -40.36% -42.52% -4.49%
EBIT 13.99% 16.71% -20.89% -47.00% -4.20%
EBITDA 14.00% 16.73% -20.90% -47.03% -4.19%
EPS Basic 12.89% 16.94% -38.46% -43.75% -5.44%
Normalized Basic EPS 12.88% 14.24% -32.68% -43.74% -5.45%
EPS Diluted 12.89% 16.94% -38.46% -43.75% -5.44%
Normalized Diluted EPS 12.88% 14.24% -32.68% -43.74% -5.45%
Average Basic Shares Outstanding 0.24% 0.39% 1.37% -0.87% -0.90%
Average Diluted Shares Outstanding 0.24% 0.39% 1.37% -0.87% -0.90%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --